Aussie GP-Training Group Boasted Of Boosting Pfizer Zoloft Sales
This article was originally published in PharmAsia News
Executive Summary
An Australian group promoting physician courses claimed it had contributed to making Pfizer Australia's Zoloft (sertraline) anti-depressant a big seller in the country